Investigators from King Saud University Release New Data on Pseudomonas aeruginosa (Antibacterial and Antibiofilm Activities of Selenium Nanoparticles-antibiotic Conjugates Against Anti-multidrug-resistant Bacteria).

Researchers from King Saud University in Riyadh, Saudi Arabia have conducted a study on the antibacterial and antibiofilm activities of selenium nanoparticles-antibiotic conjugates against multidrug-resistant bacteria, specifically Pseudomonas aeruginosa. The study found that the conjugation of selenium nanoparticles with antibiotics such as amikacin, levofloxacin, and piperacillin increased their antibacterial potency against resistant pathogens at a low concentration. The researchers suggest that these antibiotic-conjugated selenium nanoparticles have great potential for biomedical applications. The study has been peer-reviewed and published in the International Journal of Pharmaceutics. [Extracted from the article]